Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trial.
| Image |  |
|---|---|
| Description | scientific article published in April 2005 |
| Author/s |
author: Hannah Valantine |
| Publication date | April 1, 2005 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |